S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:CODX

Co-Diagnostics (CODX) Earnings Date, Estimates & Call Transcripts

$1.08
+0.02 (+1.89%)
(As of 09/26/2023 ET)
Compare
Today's Range
$1.05
▼
$1.13
50-Day Range
$1.03
▼
$1.85
52-Week Range
$0.98
▼
$3.84
Volume
44,729 shs
Average Volume
121,280 shs
Market Capitalization
$33.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 10)
-$0.31 Missed By -$0.07
Consensus EPS
(Aug. 10)
-$0.24
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CODX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CODX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Co-Diagnostics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232($0.24)($0.21)($0.23) 
Q2 20232($0.24)($0.23)($0.24) 
Q3 20232($0.29)($0.23)($0.26) 
Q4 20232($0.29)($0.21)($0.25) 
FY 20238($1.06)($0.88)($0.97) 
Q1 20242($0.29)($0.20)($0.25) 
Q2 20242($0.29)($0.20)($0.25) 
Q3 20242($0.29)($0.14)($0.22) 
Q4 20242($0.29)($0.12)($0.21) 
FY 20248($1.16)($0.66) ($0.91)

CODX Earnings Date and Information

Co-Diagnostics last announced its earnings data on August 10th, 2023. The reported ($0.31) earnings per share for the quarter, missing analysts' consensus estimates of ($0.24) by $0.07. The company had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.75 million. Co-Diagnostics has generated ($1.23) earnings per share over the last year (($1.23) diluted earnings per share). Earnings for Co-Diagnostics are expected to decrease in the coming year, from ($1.08) to ($1.15) per share. Co-Diagnostics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Co-Diagnostics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/10/2023Q2 2023($0.24)($0.31)($0.07)($0.31)$0.75 million$0.20 million
5/11/2023Q1 2023($0.23)($0.20)+$0.03($0.20)$1.10 million$0.60 million
3/16/2023Q4 2022($0.15)($0.32)($0.17)$0.04$5.50 million$1.40 million
11/10/2022Q3 2022($0.06)($0.04)+$0.02($0.04)$6.75 million$5.09 million    
8/11/2022Q2 2022$0.15($0.10)($0.25)($0.12)$20.50 million$5.02 million
5/12/2022Q1 2022$0.18$0.26+$0.08$0.18$21.25 million$22.70 million    
3/24/2022Q4 2021$0.15$0.25+$0.10$0.25$21.50 million$20.40 million    
11/11/2021Q3 2021$0.21$0.38+$0.17$0.38$24.00 million$30.10 million    
8/12/2021Q2 2021$0.22$0.33+$0.11$0.33$21.00 million$27.36 million    
5/12/2021Q1 2021$0.22$0.26+$0.04$0.26$19.50 million$20.03 million  
3/24/2021Q4 2020$0.48$0.45($0.03)$0.43$26.73 million$27.15 million  
11/15/2020Q3$0.63$0.53($0.10)$0.53$28.00 million$21.82 million  












Co-Diagnostics Earnings - Frequently Asked Questions

When is Co-Diagnostics's earnings date?

Co-Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on CODX's earnings history.

Did Co-Diagnostics beat their earnings estimates last quarter?

In the previous quarter, Co-Diagnostics (NASDAQ:CODX) missed the analysts' consensus estimate of ($0.24) by $0.07 with a reported earnings per share (EPS) of ($0.31). Learn more on analysts' earnings estimate vs. CODX's actual earnings.

How much revenue does Co-Diagnostics generate each year?

Co-Diagnostics (NASDAQ:CODX) has a recorded annual revenue of $34.22 million.

How much profit does Co-Diagnostics generate each year?

Co-Diagnostics (NASDAQ:CODX) has a recorded net income of -$14.24 million. CODX has generated -$1.23 earnings per share over the last four quarters.

What is Co-Diagnostics's EPS forecast for next year?

Co-Diagnostics's earnings are expected to decrease from ($1.08) per share to ($1.15) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:CODX) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -